By John Dike, Osogbo
Omoluabi Holdings Limited has disclosed plans to establish a strong legal framework aimed at protecting investments from political interference and policy reversals in Osun State.
Its Managing Director, Mr Taofiq Alimi, said the initiative is part of broader efforts to restore investor confidence and guarantee the sustainability of public–private partnerships across the state.
Alimi spoke in Osogbo on Thursday during Newspoint, a programme organised by the Nigeria Union of Journalists (NUJ), Correspondents’ Chape.
He explained that the agency, working through its consultants and in collaboration with the Ministry of Justice, has drafted legally binding agreements designed to prevent the arbitrary termination of investment arrangements.
According to him, the new framework is intended to ensure that business operations are insulated from political influence and managed strictly on professional and commercial principles.
“People managing these businesses will not go back to the old ways where politicians hijack investments and treat them as political tools,” Alimi said.
“The best protection we can provide is through the law, and that is exactly what we are doing.”
He noted that all current and future agreements with investors are being structured to ensure continuity, regardless of changes in political leadership.
His words, “We are working with our consultants, their legal teams, and the Ministry of Justice to make sure that whatever agreement we enter into cannot be arbitrarily discarded,”
“Nobody should be able to come in and just rubbish an investment. These projects require huge capital and long-term commitment.”
Alimi further disclosed that one of the projects covered under the new legal safeguards is the proposed drug manufacturing plant in the state. He said the agreement for the project is robust enough to prevent interference for at least 10 to 15 years after operations commence.
He explained that the project initially faced delays due to concerns raised by foreign partners over currency volatility, but said adequate assurances have now been provided to address those concerns.
“With the drug manufacturing company, we have a very solid agreement with the investor, and nobody can tamper with it, at least within the first ten to fifteen years of the business, ensuring their investment and returns are protected,” he said.
Alimi expressed optimism that the project would soon move to the implementation stage.
“In the next six months to one year, we should have something concrete on the ground.
